These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 33132434)
1. Serum surfactant protein A as a surrogate biomarker of a negative heart sign among patients with interstitial lung disease. Sasaki H; Hara Y; Taguri M; Fujikura Y; Murohashi K; Yagyu H; Kaneko T; Kawana A Nagoya J Med Sci; 2020 Aug; 82(3):499-508. PubMed ID: 33132434 [TBL] [Abstract][Full Text] [Related]
2. Arterial Carboxyhemoglobin Measurement Is Useful for Evaluating Pulmonary Inflammation in Subjects with Interstitial Lung Disease. Hara Y; Shinkai M; Kanoh S; Fujikura Y; K Rubin B; Kawana A; Kaneko T Intern Med; 2017; 56(6):621-626. PubMed ID: 28321059 [TBL] [Abstract][Full Text] [Related]
4. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Takahashi H; Kuroki Y; Tanaka H; Saito T; Kurokawa K; Chiba H; Sagawa A; Nagae H; Abe S Am J Respir Crit Care Med; 2000 Jul; 162(1):258-63. PubMed ID: 10903251 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease. Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987 [TBL] [Abstract][Full Text] [Related]
7. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease. Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031 [TBL] [Abstract][Full Text] [Related]
8. Plasma Surfactant Protein-D, Matrix Metalloproteinase-7, and Osteopontin Index Distinguishes Idiopathic Pulmonary Fibrosis from Other Idiopathic Interstitial Pneumonias. White ES; Xia M; Murray S; Dyal R; Flaherty CM; Flaherty KR; Moore BB; Cheng L; Doyle TJ; Villalba J; Dellaripa PF; Rosas IO; Kurtis JD; Martinez FJ Am J Respir Crit Care Med; 2016 Nov; 194(10):1242-1251. PubMed ID: 27149370 [TBL] [Abstract][Full Text] [Related]
9. Surfactant protein-D predicts prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer: a case control study. Nakamura K; Kato M; Shukuya T; Mori K; Sekimoto Y; Ihara H; Kanemaru R; Ko R; Shibayama R; Tajima K; Koyama R; Shimada N; Nagashima O; Takahashi F; Sasaki S; Takahashi K BMC Cancer; 2017 May; 17(1):302. PubMed ID: 28464801 [TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias. Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371 [TBL] [Abstract][Full Text] [Related]
11. Can YKL-40 be used as a biomarker for interstitial lung disease?: A systematic review and meta-analysis. Tong X; Ma Y; Liu T; Li Z; Liu S; Wu G; Fan H Medicine (Baltimore); 2021 Apr; 100(17):e25631. PubMed ID: 33907118 [TBL] [Abstract][Full Text] [Related]
12. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis. Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia. Xue M; Guo Z; Cai C; Sun B; Wang H Respiration; 2019; 98(6):534-545. PubMed ID: 31665737 [TBL] [Abstract][Full Text] [Related]
14. Human epididymis protein 4 is a new biomarker to predict the prognosis of progressive fibrosing interstitial lung disease. Nishiyama N; Masuo M; Nukui Y; Tateishi T; Kishino M; Tateishi U; Morota K; Ohbo K; Miyazaki Y Respir Investig; 2021 Jan; 59(1):90-98. PubMed ID: 32919933 [TBL] [Abstract][Full Text] [Related]
15. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity. Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823 [TBL] [Abstract][Full Text] [Related]
16. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease. Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320 [TBL] [Abstract][Full Text] [Related]
17. [Surfactant proteins-A and D as important serum markers for interstitial lung disease in patients with polymyositis or dermatomyositis]. Chen F; Shu XM; Wang DX; Xie Y; Wang GC Zhonghua Yi Xue Za Zhi; 2012 Aug; 92(31):2182-5. PubMed ID: 23158422 [TBL] [Abstract][Full Text] [Related]
18. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Kinder BW; Brown KK; McCormack FX; Ix JH; Kervitsky A; Schwarz MI; King TE Chest; 2009 Jun; 135(6):1557-1563. PubMed ID: 19255294 [TBL] [Abstract][Full Text] [Related]
19. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis. Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H Respir Med; 2019; 154():122-126. PubMed ID: 31238182 [TBL] [Abstract][Full Text] [Related]
20. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features. Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]